NP / PA
Mcgraw, Bethany
Mcgraw, Bethany was paid $233K by Medicaid between Jun 2022 and Dec 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoMCGRAW, BETHANY
GALESBURG, IL 61401
GALESBURG, IL 61401
33aNPI1063157683assigned 04/28/2022
33bProvider typeNurse Practitioner
28Total paid$233K
24GClaims5,637
24DCodes billed26
24AFirst – last monthJun 2022 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#128 of 1,687
Median peer was paid$22K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 1,983 | $79K | |
| 2023 | 2,510 | $100K | |
| 2024incomplete | 1,144 | $54K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 1,262 | 1,119 | $61K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 20% | 602 | 502 | $46K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 511 | 429 | $35K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.4% | 289 | 252 | $22K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5.5% | 686 | 603 | $13K |
| 87428 | 4.5% | 167 | 160 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.1% | 114 | 101 | $10K |
| 90670 | 2.1% | 296 | 249 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.0% | 70 | 68 | $5K |
| 90648 | 1.8% | 260 | 220 | $4K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 69 | 67 | $3K |
| 90686 | 1.2% | 174 | 137 | $3K |
14 more codes
| 90680 | 1.2% | 170 | $3K | |
| 90633 | 1.1% | 159 | $3K | |
| 83655 | 1.1% | 207 | $2K | |
| 90723 | <1% | 118 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 95 | $1K |
| 90677 | <1% | 50 | $858.44 | |
| 87807 | <1% | 86 | $855.10 | |
| 87634 | <1% | 14 | $728.00 | |
| 90710 | <1% | 43 | $706.08 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 19 | $671.27 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 21 | $586.82 |
| 90696 | <1% | 28 | $455.43 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $421.08 |
| 85018 | <1% | 115 | $266.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.